Oliver Seiler has broad experience in international equity capital markets transactions, particularly IPOs, capital increases (rights issues), blocktrades, and equity-linked transactions. He is currently advising on Siemens Healthineers’ IPO. Recently, Oliver has advised on a significant number of market-leading deals, including the IPOs of HelloFresh, Dermapharm Holding and the capital increase of E.ON (by way of an accelerated bookbuilding). Oliver is consistently recognised as a “leading name” for equity capital markets by legal directories. Clients and competitors describe him as “one of the best ECM lawyers” and a “skilled negotiator”.